May Measurement Month 2018: an analysis of blood pressure screening results from Albania

Genc Burazeri(University of Medicine Tirana), Neil R Poulter(Imperial College London), Thomas Beaney(Imperial College London), Herion Muja(Department of Health), Xin Xia(Sichuan University), Rudina Çumashi(University of Medicine Tirana), Qamil Dika(University of Medicine Tirana), Gentiana Qirjako, Alban Ylli(University of Medicine Tirana), Enver Roshi, Anca Chis Ster(Imperial College London)
European Heart Journal Supplements
August 1, 2020
10.1093/eurheartj/suaa014
Cited by 3

Related Papers

Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes
|New England Journal of Medicine|2008|7.4k
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial
|The Lancet|2003|3.8k
Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial
|The Lancet|2005|2.9k
Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2017|2.1k
Interpretation of the evidence for the efficacy and safety of statin therapy
|The Lancet|2016|1.8k